Global Gastrointestinal Cancer Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 107

Published Date: 06 Jan 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Gastrointestinal Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Gastrointestinal Cancer Drugs market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during review period. Hospitals accounting for % of the Gastrointestinal Cancer Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oncology segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Gastrointestinal Cancer Drugs include Amgen & Amgen Ireland, Bristol-Myers Squibb Company, Roche, Eli Lilly and Company, and Johnson & Johnson Private, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Gastrointestinal Cancer Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Oncology
    Radiology
    Others

Market segment by Application can be divided into
    Hospitals
    Specialized Cancer Treatment Centers
    Clinics
    Ambulatory Surgical Centers

The key market players for global Gastrointestinal Cancer Drugs market are listed below:
    Amgen & Amgen Ireland
    Bristol-Myers Squibb Company
    Roche
    Eli Lilly and Company
    Johnson & Johnson Private
    GlaxoSmithKline
    Celgene Corporation
    Pfizer
    Sanofi
    Novartis

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastrointestinal Cancer Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gastrointestinal Cancer Drugs, with price, sales, revenue and global market share of Gastrointestinal Cancer Drugs from 2019 to 2022.
Chapter 3, the Gastrointestinal Cancer Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastrointestinal Cancer Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Gastrointestinal Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastrointestinal Cancer Drugs.
Chapter 13, 14, and 15, to describe Gastrointestinal Cancer Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Gastrointestinal Cancer Drugs Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Gastrointestinal Cancer Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Oncology
        1.2.3 Radiology
        1.2.4 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Gastrointestinal Cancer Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospitals
        1.3.3 Specialized Cancer Treatment Centers
        1.3.4 Clinics
        1.3.5 Ambulatory Surgical Centers
    1.4 Global Gastrointestinal Cancer Drugs Market Size & Forecast
        1.4.1 Global Gastrointestinal Cancer Drugs Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Gastrointestinal Cancer Drugs Sales in Volume (2017-2028)
        1.4.3 Global Gastrointestinal Cancer Drugs Price (2017-2028)
    1.5 Global Gastrointestinal Cancer Drugs Production Capacity Analysis
        1.5.1 Global Gastrointestinal Cancer Drugs Total Production Capacity (2017-2028)
        1.5.2 Global Gastrointestinal Cancer Drugs Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Gastrointestinal Cancer Drugs Market Drivers
        1.6.2 Gastrointestinal Cancer Drugs Market Restraints
        1.6.3 Gastrointestinal Cancer Drugs Trends Analysis

2 Manufacturers Profiles
    2.1 Amgen & Amgen Ireland
        2.1.1 Amgen & Amgen Ireland Details
        2.1.2 Amgen & Amgen Ireland Major Business
        2.1.3 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product and Services
        2.1.4 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Bristol-Myers Squibb Company
        2.2.1 Bristol-Myers Squibb Company Details
        2.2.2 Bristol-Myers Squibb Company Major Business
        2.2.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product and Services
        2.2.4 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Roche
        2.3.1 Roche Details
        2.3.2 Roche Major Business
        2.3.3 Roche Gastrointestinal Cancer Drugs Product and Services
        2.3.4 Roche Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Eli Lilly and Company
        2.4.1 Eli Lilly and Company Details
        2.4.2 Eli Lilly and Company Major Business
        2.4.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Product and Services
        2.4.4 Eli Lilly and Company Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Johnson & Johnson Private
        2.5.1 Johnson & Johnson Private Details
        2.5.2 Johnson & Johnson Private Major Business
        2.5.3 Johnson & Johnson Private Gastrointestinal Cancer Drugs Product and Services
        2.5.4 Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 GlaxoSmithKline
        2.6.1 GlaxoSmithKline Details
        2.6.2 GlaxoSmithKline Major Business
        2.6.3 GlaxoSmithKline Gastrointestinal Cancer Drugs Product and Services
        2.6.4 GlaxoSmithKline Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Celgene Corporation
        2.7.1 Celgene Corporation Details
        2.7.2 Celgene Corporation Major Business
        2.7.3 Celgene Corporation Gastrointestinal Cancer Drugs Product and Services
        2.7.4 Celgene Corporation Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Pfizer
        2.8.1 Pfizer Details
        2.8.2 Pfizer Major Business
        2.8.3 Pfizer Gastrointestinal Cancer Drugs Product and Services
        2.8.4 Pfizer Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Sanofi
        2.9.1 Sanofi Details
        2.9.2 Sanofi Major Business
        2.9.3 Sanofi Gastrointestinal Cancer Drugs Product and Services
        2.9.4 Sanofi Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Novartis
        2.10.1 Novartis Details
        2.10.2 Novartis Major Business
        2.10.3 Novartis Gastrointestinal Cancer Drugs Product and Services
        2.10.4 Novartis Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Gastrointestinal Cancer Drugs Breakdown Data by Manufacturer
    3.1 Global Gastrointestinal Cancer Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Gastrointestinal Cancer Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Gastrointestinal Cancer Drugs
    3.4 Market Concentration Rate
        3.4.1 Top 3 Gastrointestinal Cancer Drugs Manufacturer Market Share in 2021
        3.4.2 Top 6 Gastrointestinal Cancer Drugs Manufacturer Market Share in 2021
    3.5 Global Gastrointestinal Cancer Drugs Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Gastrointestinal Cancer Drugs Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Gastrointestinal Cancer Drugs Market Size by Region
        4.1.1 Global Gastrointestinal Cancer Drugs Sales in Volume by Region (2017-2028)
        4.1.2 Global Gastrointestinal Cancer Drugs Revenue by Region (2017-2028)
    4.2 North America Gastrointestinal Cancer Drugs Revenue (2017-2028)
    4.3 Europe Gastrointestinal Cancer Drugs Revenue (2017-2028)
    4.4 Asia-Pacific Gastrointestinal Cancer Drugs Revenue (2017-2028)
    4.5 South America Gastrointestinal Cancer Drugs Revenue (2017-2028)
    4.6 Middle East and Africa Gastrointestinal Cancer Drugs Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Gastrointestinal Cancer Drugs Sales in Volume by Type (2017-2028)
    5.2 Global Gastrointestinal Cancer Drugs Revenue by Type (2017-2028)
    5.3 Global Gastrointestinal Cancer Drugs Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Gastrointestinal Cancer Drugs Sales in Volume by Application (2017-2028)
    6.2 Global Gastrointestinal Cancer Drugs Revenue by Application (2017-2028)
    6.3 Global Gastrointestinal Cancer Drugs Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Gastrointestinal Cancer Drugs Sales by Type (2017-2028)
    7.2 North America Gastrointestinal Cancer Drugs Sales by Application (2017-2028)
    7.3 North America Gastrointestinal Cancer Drugs Market Size by Country
        7.3.1 North America Gastrointestinal Cancer Drugs Sales in Volume by Country (2017-2028)
        7.3.2 North America Gastrointestinal Cancer Drugs Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Gastrointestinal Cancer Drugs Sales by Type (2017-2028)
    8.2 Europe Gastrointestinal Cancer Drugs Sales by Application (2017-2028)
    8.3 Europe Gastrointestinal Cancer Drugs Market Size by Country
        8.3.1 Europe Gastrointestinal Cancer Drugs Sales in Volume by Country (2017-2028)
        8.3.2 Europe Gastrointestinal Cancer Drugs Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Gastrointestinal Cancer Drugs Sales by Type (2017-2028)
    9.2 Asia-Pacific Gastrointestinal Cancer Drugs Sales by Application (2017-2028)
    9.3 Asia-Pacific Gastrointestinal Cancer Drugs Market Size by Region
        9.3.1 Asia-Pacific Gastrointestinal Cancer Drugs Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Gastrointestinal Cancer Drugs Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Gastrointestinal Cancer Drugs Sales by Type (2017-2028)
    10.2 South America Gastrointestinal Cancer Drugs Sales by Application (2017-2028)
    10.3 South America Gastrointestinal Cancer Drugs Market Size by Country
        10.3.1 South America Gastrointestinal Cancer Drugs Sales in Volume by Country (2017-2028)
        10.3.2 South America Gastrointestinal Cancer Drugs Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Gastrointestinal Cancer Drugs Sales by Type (2017-2028)
    11.2 Middle East & Africa Gastrointestinal Cancer Drugs Sales by Application (2017-2028)
    11.3 Middle East & Africa Gastrointestinal Cancer Drugs Market Size by Country
        11.3.1 Middle East & Africa Gastrointestinal Cancer Drugs Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Gastrointestinal Cancer Drugs Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Gastrointestinal Cancer Drugs and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Gastrointestinal Cancer Drugs
    12.3 Gastrointestinal Cancer Drugs Production Process
    12.4 Gastrointestinal Cancer Drugs Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Gastrointestinal Cancer Drugs Typical Distributors
    13.3 Gastrointestinal Cancer Drugs Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gastrointestinal Cancer Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Gastrointestinal Cancer Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. Amgen & Amgen Ireland Basic Information, Manufacturing Base and Competitors
    Table 4. Amgen & Amgen Ireland Major Business
    Table 5. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product and Services
    Table 6. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
    Table 8. Bristol-Myers Squibb Company Major Business
    Table 9. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product and Services
    Table 10. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. Roche Basic Information, Manufacturing Base and Competitors
    Table 12. Roche Major Business
    Table 13. Roche Gastrointestinal Cancer Drugs Product and Services
    Table 14. Roche Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
    Table 16. Eli Lilly and Company Major Business
    Table 17. Eli Lilly and Company Gastrointestinal Cancer Drugs Product and Services
    Table 18. Eli Lilly and Company Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. Johnson & Johnson Private Basic Information, Manufacturing Base and Competitors
    Table 20. Johnson & Johnson Private Major Business
    Table 21. Johnson & Johnson Private Gastrointestinal Cancer Drugs Product and Services
    Table 22. Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 24. GlaxoSmithKline Major Business
    Table 25. GlaxoSmithKline Gastrointestinal Cancer Drugs Product and Services
    Table 26. GlaxoSmithKline Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. Celgene Corporation Basic Information, Manufacturing Base and Competitors
    Table 28. Celgene Corporation Major Business
    Table 29. Celgene Corporation Gastrointestinal Cancer Drugs Product and Services
    Table 30. Celgene Corporation Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 32. Pfizer Major Business
    Table 33. Pfizer Gastrointestinal Cancer Drugs Product and Services
    Table 34. Pfizer Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 36. Sanofi Major Business
    Table 37. Sanofi Gastrointestinal Cancer Drugs Product and Services
    Table 38. Sanofi Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 39. Novartis Basic Information, Manufacturing Base and Competitors
    Table 40. Novartis Major Business
    Table 41. Novartis Gastrointestinal Cancer Drugs Product and Services
    Table 42. Novartis Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 43. Global Gastrointestinal Cancer Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
    Table 44. Global Gastrointestinal Cancer Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 45. Market Position of Manufacturers in Gastrointestinal Cancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 46. Global Gastrointestinal Cancer Drugs Production Capacity by Company, (K Units): 2020 VS 2021
    Table 47. Head Office and Gastrointestinal Cancer Drugs Production Site of Key Manufacturer
    Table 48. Gastrointestinal Cancer Drugs New Entrant and Capacity Expansion Plans
    Table 49. Gastrointestinal Cancer Drugs Mergers & Acquisitions in the Past Five Years
    Table 50. Global Gastrointestinal Cancer Drugs Sales by Region (2017-2022) & (K Units)
    Table 51. Global Gastrointestinal Cancer Drugs Sales by Region (2023-2028) & (K Units)
    Table 52. Global Gastrointestinal Cancer Drugs Revenue by Region (2017-2022) & (USD Million)
    Table 53. Global Gastrointestinal Cancer Drugs Revenue by Region (2023-2028) & (USD Million)
    Table 54. Global Gastrointestinal Cancer Drugs Sales by Type (2017-2022) & (K Units)
    Table 55. Global Gastrointestinal Cancer Drugs Sales by Type (2023-2028) & (K Units)
    Table 56. Global Gastrointestinal Cancer Drugs Revenue by Type (2017-2022) & (USD Million)
    Table 57. Global Gastrointestinal Cancer Drugs Revenue by Type (2023-2028) & (USD Million)
    Table 58. Global Gastrointestinal Cancer Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 59. Global Gastrointestinal Cancer Drugs Price by Type (2023-2028) & (USD/Unit)
    Table 60. Global Gastrointestinal Cancer Drugs Sales by Application (2017-2022) & (K Units)
    Table 61. Global Gastrointestinal Cancer Drugs Sales by Application (2023-2028) & (K Units)
    Table 62. Global Gastrointestinal Cancer Drugs Revenue by Application (2017-2022) & (USD Million)
    Table 63. Global Gastrointestinal Cancer Drugs Revenue by Application (2023-2028) & (USD Million)
    Table 64. Global Gastrointestinal Cancer Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 65. Global Gastrointestinal Cancer Drugs Price by Application (2023-2028) & (USD/Unit)
    Table 66. North America Gastrointestinal Cancer Drugs Sales by Country (2017-2022) & (K Units)
    Table 67. North America Gastrointestinal Cancer Drugs Sales by Country (2023-2028) & (K Units)
    Table 68. North America Gastrointestinal Cancer Drugs Revenue by Country (2017-2022) & (USD Million)
    Table 69. North America Gastrointestinal Cancer Drugs Revenue by Country (2023-2028) & (USD Million)
    Table 70. North America Gastrointestinal Cancer Drugs Sales by Type (2017-2022) & (K Units)
    Table 71. North America Gastrointestinal Cancer Drugs Sales by Type (2023-2028) & (K Units)
    Table 72. North America Gastrointestinal Cancer Drugs Sales by Application (2017-2022) & (K Units)
    Table 73. North America Gastrointestinal Cancer Drugs Sales by Application (2023-2028) & (K Units)
    Table 74. Europe Gastrointestinal Cancer Drugs Sales by Country (2017-2022) & (K Units)
    Table 75. Europe Gastrointestinal Cancer Drugs Sales by Country (2023-2028) & (K Units)
    Table 76. Europe Gastrointestinal Cancer Drugs Revenue by Country (2017-2022) & (USD Million)
    Table 77. Europe Gastrointestinal Cancer Drugs Revenue by Country (2023-2028) & (USD Million)
    Table 78. Europe Gastrointestinal Cancer Drugs Sales by Type (2017-2022) & (K Units)
    Table 79. Europe Gastrointestinal Cancer Drugs Sales by Type (2023-2028) & (K Units)
    Table 80. Europe Gastrointestinal Cancer Drugs Sales by Application (2017-2022) & (K Units)
    Table 81. Europe Gastrointestinal Cancer Drugs Sales by Application (2023-2028) & (K Units)
    Table 82. Asia-Pacific Gastrointestinal Cancer Drugs Sales by Region (2017-2022) & (K Units)
    Table 83. Asia-Pacific Gastrointestinal Cancer Drugs Sales by Region (2023-2028) & (K Units)
    Table 84. Asia-Pacific Gastrointestinal Cancer Drugs Revenue by Region (2017-2022) & (USD Million)
    Table 85. Asia-Pacific Gastrointestinal Cancer Drugs Revenue by Region (2023-2028) & (USD Million)
    Table 86. Asia-Pacific Gastrointestinal Cancer Drugs Sales by Type (2017-2022) & (K Units)
    Table 87. Asia-Pacific Gastrointestinal Cancer Drugs Sales by Type (2023-2028) & (K Units)
    Table 88. Asia-Pacific Gastrointestinal Cancer Drugs Sales by Application (2017-2022) & (K Units)
    Table 89. Asia-Pacific Gastrointestinal Cancer Drugs Sales by Application (2023-2028) & (K Units)
    Table 90. South America Gastrointestinal Cancer Drugs Sales by Country (2017-2022) & (K Units)
    Table 91. South America Gastrointestinal Cancer Drugs Sales by Country (2023-2028) & (K Units)
    Table 92. South America Gastrointestinal Cancer Drugs Revenue by Country (2017-2022) & (USD Million)
    Table 93. South America Gastrointestinal Cancer Drugs Revenue by Country (2023-2028) & (USD Million)
    Table 94. South America Gastrointestinal Cancer Drugs Sales by Type (2017-2022) & (K Units)
    Table 95. South America Gastrointestinal Cancer Drugs Sales by Type (2023-2028) & (K Units)
    Table 96. South America Gastrointestinal Cancer Drugs Sales by Application (2017-2022) & (K Units)
    Table 97. South America Gastrointestinal Cancer Drugs Sales by Application (2023-2028) & (K Units)
    Table 98. Middle East & Africa Gastrointestinal Cancer Drugs Sales by Region (2017-2022) & (K Units)
    Table 99. Middle East & Africa Gastrointestinal Cancer Drugs Sales by Region (2023-2028) & (K Units)
    Table 100. Middle East & Africa Gastrointestinal Cancer Drugs Revenue by Region (2017-2022) & (USD Million)
    Table 101. Middle East & Africa Gastrointestinal Cancer Drugs Revenue by Region (2023-2028) & (USD Million)
    Table 102. Middle East & Africa Gastrointestinal Cancer Drugs Sales by Type (2017-2022) & (K Units)
    Table 103. Middle East & Africa Gastrointestinal Cancer Drugs Sales by Type (2023-2028) & (K Units)
    Table 104. Middle East & Africa Gastrointestinal Cancer Drugs Sales by Application (2017-2022) & (K Units)
    Table 105. Middle East & Africa Gastrointestinal Cancer Drugs Sales by Application (2023-2028) & (K Units)
    Table 106. Gastrointestinal Cancer Drugs Raw Material
    Table 107. Key Manufacturers of Gastrointestinal Cancer Drugs Raw Materials
    Table 108. Direct Channel Pros & Cons
    Table 109. Indirect Channel Pros & Cons
    Table 110. Gastrointestinal Cancer Drugs Typical Distributors
    Table 111. Gastrointestinal Cancer Drugs Typical Customers
List of Figures
    Figure 1. Gastrointestinal Cancer Drugs Picture
    Figure 2. Global Gastrointestinal Cancer Drugs Revenue Market Share by Type in 2021
    Figure 3. Oncology
    Figure 4. Radiology
    Figure 5. Others
    Figure 6. Global Gastrointestinal Cancer Drugs Revenue Market Share by Application in 2021
    Figure 7. Hospitals
    Figure 8. Specialized Cancer Treatment Centers
    Figure 9. Clinics
    Figure 10. Ambulatory Surgical Centers
    Figure 11. Global Gastrointestinal Cancer Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
    Figure 12. Global Gastrointestinal Cancer Drugs Revenue and Forecast (2017-2028) & (USD Million)
    Figure 13. Global Gastrointestinal Cancer Drugs Sales (2017-2028) & (K Units)
    Figure 14. Global Gastrointestinal Cancer Drugs Price (2017-2028) & (USD/Unit)
    Figure 15. Global Gastrointestinal Cancer Drugs Production Capacity (2017-2028) & (K Units)
    Figure 16. Global Gastrointestinal Cancer Drugs Production Capacity by Geographic Region: 2022 VS 2028
    Figure 17. Gastrointestinal Cancer Drugs Market Drivers
    Figure 18. Gastrointestinal Cancer Drugs Market Restraints
    Figure 19. Gastrointestinal Cancer Drugs Market Trends
    Figure 20. Global Gastrointestinal Cancer Drugs Sales Market Share by Manufacturer in 2021
    Figure 21. Global Gastrointestinal Cancer Drugs Revenue Market Share by Manufacturer in 2021
    Figure 22. Gastrointestinal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 23. Top 3 Gastrointestinal Cancer Drugs Manufacturer (Revenue) Market Share in 2021
    Figure 24. Top 6 Gastrointestinal Cancer Drugs Manufacturer (Revenue) Market Share in 2021
    Figure 25. Global Gastrointestinal Cancer Drugs Sales Market Share by Region (2017-2028)
    Figure 26. Global Gastrointestinal Cancer Drugs Revenue Market Share by Region (2017-2028)
    Figure 27. North America Gastrointestinal Cancer Drugs Revenue (2017-2028) & (USD Million)
    Figure 28. Europe Gastrointestinal Cancer Drugs Revenue (2017-2028) & (USD Million)
    Figure 29. Asia-Pacific Gastrointestinal Cancer Drugs Revenue (2017-2028) & (USD Million)
    Figure 30. South America Gastrointestinal Cancer Drugs Revenue (2017-2028) & (USD Million)
    Figure 31. Middle East & Africa Gastrointestinal Cancer Drugs Revenue (2017-2028) & (USD Million)
    Figure 32. Global Gastrointestinal Cancer Drugs Sales Market Share by Type (2017-2028)
    Figure 33. Global Gastrointestinal Cancer Drugs Revenue Market Share by Type (2017-2028)
    Figure 34. Global Gastrointestinal Cancer Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 35. Global Gastrointestinal Cancer Drugs Sales Market Share by Application (2017-2028)
    Figure 36. Global Gastrointestinal Cancer Drugs Revenue Market Share by Application (2017-2028)
    Figure 37. Global Gastrointestinal Cancer Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 38. North America Gastrointestinal Cancer Drugs Sales Market Share by Type (2017-2028)
    Figure 39. North America Gastrointestinal Cancer Drugs Sales Market Share by Application (2017-2028)
    Figure 40. North America Gastrointestinal Cancer Drugs Sales Market Share by Country (2017-2028)
    Figure 41. North America Gastrointestinal Cancer Drugs Revenue Market Share by Country (2017-2028)
    Figure 42. United States Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Canada Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 44. Mexico Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 45. Europe Gastrointestinal Cancer Drugs Sales Market Share by Type (2017-2028)
    Figure 46. Europe Gastrointestinal Cancer Drugs Sales Market Share by Application (2017-2028)
    Figure 47. Europe Gastrointestinal Cancer Drugs Sales Market Share by Country (2017-2028)
    Figure 48. Europe Gastrointestinal Cancer Drugs Revenue Market Share by Country (2017-2028)
    Figure 49. Germany Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. France Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. United Kingdom Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Russia Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. Italy Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 54. Asia-Pacific Gastrointestinal Cancer Drugs Sales Market Share by Region (2017-2028)
    Figure 55. Asia-Pacific Gastrointestinal Cancer Drugs Sales Market Share by Application (2017-2028)
    Figure 56. Asia-Pacific Gastrointestinal Cancer Drugs Sales Market Share by Region (2017-2028)
    Figure 57. Asia-Pacific Gastrointestinal Cancer Drugs Revenue Market Share by Region (2017-2028)
    Figure 58. China Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. Japan Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Korea Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. India Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. Southeast Asia Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. Australia Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. South America Gastrointestinal Cancer Drugs Sales Market Share by Type (2017-2028)
    Figure 65. South America Gastrointestinal Cancer Drugs Sales Market Share by Application (2017-2028)
    Figure 66. South America Gastrointestinal Cancer Drugs Sales Market Share by Country (2017-2028)
    Figure 67. South America Gastrointestinal Cancer Drugs Revenue Market Share by Country (2017-2028)
    Figure 68. Brazil Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 69. Argentina Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 70. Middle East & Africa Gastrointestinal Cancer Drugs Sales Market Share by Type (2017-2028)
    Figure 71. Middle East & Africa Gastrointestinal Cancer Drugs Sales Market Share by Application (2017-2028)
    Figure 72. Middle East & Africa Gastrointestinal Cancer Drugs Sales Market Share by Region (2017-2028)
    Figure 73. Middle East & Africa Gastrointestinal Cancer Drugs Revenue Market Share by Region (2017-2028)
    Figure 74. Turkey Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. Egypt Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. Saudi Arabia Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. South Africa Gastrointestinal Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 78. Manufacturing Cost Structure Analysis of Gastrointestinal Cancer Drugs in 2021
    Figure 79. Manufacturing Process Analysis of Gastrointestinal Cancer Drugs
    Figure 80. Gastrointestinal Cancer Drugs Industrial Chain
    Figure 81. Sales Channel: Direct Channel vs Indirect Channel
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Amgen & Amgen Ireland
Bristol-Myers Squibb Company
Roche
Eli Lilly and Company
Johnson & Johnson Private
GlaxoSmithKline
Celgene Corporation
Pfizer
Sanofi
Novartis

Related Reports

Global Gastrointestinal Cancer Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Gastrointestinal Cancer Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 25 Feb 2021

date Pharma & Healthcare

The Gastrointestinal Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Gastrointestinal Cancer Drugs Supply, Demand and Key Producers, 2023-2029

Global Gastrointestinal Cancer Drugs Supply, Demand and Key Producers, 2023-2029

date 01 Feb 2023

date Pharma & Healthcare

Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems.

Global Gastrointestinal Cancer Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Gastrointestinal Cancer Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 06 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Gastrointestinal Cancer Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

gastrointestinal cancer drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>